Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer

被引:23
|
作者
Ji, Huihui [1 ]
Zhang, Jian-an [1 ]
Liu, Hejing [1 ]
Li, Kehan [1 ]
Wang, Zhi-wei [1 ]
Zhu, Xueqiong [1 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 2, Ctr Uterine Canc Diag & Therapy Res Zhejiang Prov, Dept Obstet & Gynecol, Wenzhou, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
基金
中国国家自然科学基金;
关键词
cervical cancer; M6A; TME; PD-1; PD-L1; TIME; MESSENGER-RNA; CELLS;
D O I
10.3389/fimmu.2022.976107
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Understanding the role of N6-adenosine methylation (m6A) in the tumor microenvironment (TME) is important since it can contribute to tumor development. However, the research investigating the association between m6A and TME and cervical cancer is still in its early stages. The aim of this study was to discover the possible relationship between m6A RNA methylation regulators, TME, PD-L1 expression levels, and immune infiltration in cervical cancer. We gathered RNA-seq transcriptome data and clinical information from cervical cancer patients using The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases. To begin, researchers assessed the differences in m6A regulatory factor expression levels between cervical cancer and normal tissues. Clustering analysis was adapted to assess PD-L1 expression, immunological score, immune cell infiltration, TME, and probable pathways in cervical cancer samples. The majority of m6A regulators were found to be considerably overexpressed in cervical cancer tissues. Using consensus clustering of 21 m6A regulators, we identified two subtypes (clusters 1/2) of cervical cancer, and we found that WHO stage and grade were associated with the subtypes. PD-L1 expression increased dramatically in cervical cancer tissues and was significantly linked to ALKBH5, FTO, METTL3, RBM15B, YTHDF1, YTHDF3, and ZC3H13 expression levels. Plasma cells and regulatory T cells (Tregs) were considerably elevated in cluster 2. Cluster 1 is involved in numerous signature pathways, including basal transcription factors, cell cycle, RNA degradation, and the spliceosome. The prognostic signature-based riskscore (METTL16, YTHDF1, and ZC3H13) was found to be an independent prognostic indicator of cervical cancer. The tumor immune microenvironment (TIME) was linked to m6A methylation regulators, and changes in their copy number will affect the quantity of tumor-infiltrating immune cells dynamically. Overall, our research discovered a powerful predictive signature based on m6A RNA methylation regulators. This signature correctly predicted the prognosis of cervical cancer patients. The m6A methylation regulator could be a critical mediator of PD-L1 expression and immune cell infiltration, and it could have a significant impact on the TIME of cervical cancer.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Characterization of m6A methylation modifications and tumor microenvironment infiltration in thyroid cancer
    Ji, Fei-Hong
    Yang, Zhen
    Sun, Chenyu
    Lowe, Scott
    Qiu, Xin-Guang
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (01): : 269 - 282
  • [22] Characterization of m6A methylation modifications and tumor microenvironment infiltration in thyroid cancer
    Fei-Hong Ji
    Zhen yang
    Chenyu Sun
    Scott Lowe
    Xin-Guang Qiu
    Clinical and Translational Oncology, 2023, 25 : 269 - 282
  • [23] m6A RNA Methylation Regulators Impact Prognosis and Tumor Microenvironment in Renal Papillary Cell Carcinoma
    Chen, Lianze
    Hu, Baohui
    Song, Xinyue
    Wang, Lin
    Ju, Mingyi
    Li, Zinan
    Zhou, Chenyi
    Zhang, Ming
    Wei, Qian
    Guan, Qiutong
    Jiang, Longyang
    Chen, Ting
    Wei, Minjie
    Zhao, Lin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [24] Comprehensive characterization of m6A methylation and its impact on prognosis, genome instability, and tumor microenvironment in hepatocellular carcinoma
    Yin, Tengfei
    Zhao, Lang
    Yao, Shukun
    BMC MEDICAL GENOMICS, 2022, 15 (01)
  • [25] Comprehensive characterization of m6A methylation and its impact on prognosis, genome instability, and tumor microenvironment in hepatocellular carcinoma
    Tengfei Yin
    Lang Zhao
    Shukun Yao
    BMC Medical Genomics, 15
  • [26] Analysis of m6A Methylation Modification Patterns and Tumor Immune Microenvironment in Breast Cancer
    Dong, Menglu
    Shen, Wenzhuang
    Yang, Guang
    Yang, Zhifang
    Li, Xingrui
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [27] Molecular characterization of m6A RNA methylation regulators with features of immune dysregulation in IgA nephropathy
    Wang, Yihao
    Sun, Nan
    He, Rui
    Wang, Zida
    Jin, Jingsi
    Gao, Ting
    Qu, Junwen
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [28] Landscape of m6A RNA methylation regulators in liver cancer and its therapeutic implications
    Zhao, Jindu
    Li, Guo-Ying
    Lu, Xian-Ying
    Zhu, Li-Ran
    Gao, Qun
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [29] Characterization of ligamentum flavum hypertrophy based on m6A RNA methylation modification and the immune microenvironment
    He, Zhongyuan
    Zhu, Zhengya
    Tang, Tao
    Guo, Peng
    Gao, Manman
    Li, Baoliang
    Nguyen, Tran Canh Tung
    Chen, Hongkun
    Liu, Xizhe
    Zhou, Zhiyu
    Liu, Shaoyu
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (12): : 8800 - +
  • [30] m6A regulator-mediated methylation modification patterns and tumor immune microenvironment characterization in endometrial cancer
    Li, Kexin
    Shu, Shanrong
    Zou, Jiahua
    Li, Manmei
    Liu, Zhong
    GENES & DISEASES, 2023, 10 (06) : 2278 - 2281